Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
about
Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experiencePharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphismGemcitabine in metastatic breast cancer.Role of gemcitabine in cancer therapy.A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursPrimary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study.Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer.Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.Gemcitabine in combination with paclitaxel for the treatment of metastatic breast cancer.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
P2860
Q33237182-B2BFA3BD-85D1-4BBD-B3D5-A7448EAAF843Q33847161-F1C6A947-F363-45FE-970A-E371CB01C5C1Q36185611-5DD48592-0E65-4768-90C1-5A554489E577Q36429373-2750FB4F-FD0E-40F8-9701-C92235A0403BQ36608636-897E6F52-B2C8-4179-ABCC-72D4E3F442EDQ36615222-9BD64F00-D3CE-4D0A-BC71-0C0D19ED4467Q36673766-CC5C0E50-48D1-4F97-A74D-0A3A0B83A019Q36696923-7020555C-FCD6-49DD-AE26-8EE55B36277DQ37695504-099FA162-BA27-4C37-BC89-2ABAB7D83CF9Q43267072-FE079673-4F39-4B67-BA50-28BBE4E83F69Q44067892-324757C4-CA11-410D-ADB8-673EBCF9F2D0Q44351257-F93073F3-D0E2-46E8-969F-ED3FC9860AA3
P2860
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
@en
Gemcitabine plus epirubicin plus taxol
@nl
type
label
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
@en
Gemcitabine plus epirubicin plus taxol
@nl
prefLabel
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
@en
Gemcitabine plus epirubicin plus taxol
@nl
P2093
P2860
P356
P1476
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
@en
P2093
B Salvadori
C Orlandini
I Pazzagli
M Del Tacca
P2860
P2888
P304
P356
10.1023/A:1011945623464
P407
P577
2001-07-01T00:00:00Z
P6179
1039264693